BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22796282)

  • 1. Anti-phosphatidylethanolamine antibody, thromboembolic events and the antiphospholipid syndrome.
    Staub HL; Bertolaccini ML; Khamashta MA
    Autoimmun Rev; 2012 Dec; 12(2):230-4. PubMed ID: 22796282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-phosphatidylethanolamine (aPE) antibodies: a survey.
    Mcintyre JA; Wagenknecht DR
    J Autoimmun; 2000 Sep; 15(2):185-93. PubMed ID: 10968907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphosphatidylethanolamine antibodies and the antiphospholipid syndrome.
    Sanmarco M; Boffa MC
    Lupus; 2009 Sep; 18(10):920-3. PubMed ID: 19671793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity.
    Ruffatti A; Tonello M; Del Ross T; Cavazzana A; Grava C; Noventa F; Tona F; Iliceto S; Pengo V
    Thromb Haemost; 2006 Sep; 96(3):337-41. PubMed ID: 16953276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of antiphosphatidylethanolamine antibodies in the diagnosis of the antiphospholipid syndrome.
    Sanmarco M; Bardin N
    Lupus; 2012 Jun; 21(7):727-8. PubMed ID: 22635214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiphosphatidylethanolamine antibody as a marker of antiphospholipid syndrome?].
    Yelnik CM; Dubucquoi S; Houfflin-Debarge V; Lambert M
    Presse Med; 2015 Mar; 44(3):284-91. PubMed ID: 25542711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic events during long-term follow-up of obstetric antiphospholipid syndrome patients.
    Lefèvre G; Lambert M; Bacri JL; Dubucquoi S; Quemeneur T; Caron C; Launay D; Houfflin-Debarge V; Hachulla E; Kyndt X; Subtil D; Hatron PY
    Lupus; 2011 Jul; 20(8):861-5. PubMed ID: 21546412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex.
    Sugi T; McIntyre JA
    Blood; 1995 Oct; 86(8):3083-9. PubMed ID: 7579402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
    Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
    Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of antiphosphatidylethanolamine antibodies in the so-called "seronegative antiphospholipid syndrome".
    Sanmarco M
    Autoimmun Rev; 2009 Dec; 9(2):90-2. PubMed ID: 19306951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thromboses.
    Sanmarco M; Alessi MC; Harle JR; Sapin C; Aillaud MF; Gentile S; Juhan-Vague I; Weiller PJ
    Thromb Haemost; 2001 May; 85(5):800-5. PubMed ID: 11372671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibody syndrome.
    Sangle NA; Smock KJ
    Arch Pathol Lab Med; 2011 Sep; 135(9):1092-6. PubMed ID: 21877992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
    Lopez LR; Dier KJ; Lopez D; Merrill JT; Fink CA
    Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstetric and vascular APS: same autoantibodies but different diseases?
    Meroni PL; Raschi E; Grossi C; Pregnolato F; Trespidi L; Acaia B; Borghi MO
    Lupus; 2012 Jun; 21(7):708-10. PubMed ID: 22635208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies.
    Ichikawa K; Tsutsumi A; Atsumi T; Matsuura E; Kobayashi S; Hughes GR; Khamashta MA; Koike T
    Arthritis Rheum; 1999 Nov; 42(11):2461-70. PubMed ID: 10555042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.